Title:
新規化合物
Document Type and Number:
Japanese Patent JP2012511028
Kind Code:
A
Abstract:
corresponding manufacture processes, pharmaceutical formulations containing and uses of the aforementioned compound in therapy, particularly in treatment of diseases where under-activation of the HM74A receptor contributes to the disease or where activation of the receptor will be beneficial.
Inventors:
Holly, Esken
Beth, Adams, Norton
Beth, Adams, Norton
Application Number:
JP2011539772A
Publication Date:
May 17, 2012
Filing Date:
December 07, 2009
Export Citation:
Assignee:
GlaxoSmithKline LLC
International Classes:
C07D473/06; A61K31/40; A61K31/455; A61K31/522; A61K45/00; A61P1/14; A61P3/04; A61P3/06; A61P3/10; A61P7/02; A61P9/00; A61P9/04; A61P9/10; A61P9/14; A61P13/12
Domestic Patent References:
| JP2007522176A | 2007-08-09 | |||
| JPS5523825B1 | 1980-06-25 | |||
| JP2003534238A | 2003-11-18 | |||
| JPS61115051A | 1986-06-02 |
Attorney, Agent or Firm:
Hirohito Katsunuma
Yukitaka Nakamura
Noritaka Yokota
Takeyasu Ito
Yukitaka Nakamura
Noritaka Yokota
Takeyasu Ito